Please login to the form below

Not currently logged in
Email:
Password:

rolapitant

This page shows the latest rolapitant news and features for those working in and with pharma, biotech and healthcare.

Tesaro joins PARP parade with US approval of Zejula

Tesaro joins PARP parade with US approval of Zejula

The approval comes at a buoyant time for Tesaro, which is still rolling out its first commercial product in the US - the chemotherapy-induced nausea and vomiting drug Varubi (rolapitant) - and

Latest news

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
BASTARD . LONDON

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics